<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04680728</url>
  </required_header>
  <id_info>
    <org_study_id>GUINOT 2020</org_study_id>
    <nct_id>NCT04680728</nct_id>
  </id_info>
  <brief_title>Venous Congestion and Organ Dysfunction.</brief_title>
  <acronym>CoDoRéa</acronym>
  <official_title>Venous Congestion and Organ Dysfunction in Intensive Care: a Prospective, Multicenter, Observational Study to Evaluate Prevalence and Risk Factors.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Venous congestion, which is a phenomenon described in cardiology and post-operative cardiac&#xD;
      surgery, is responsible for an increase in morbidity and mortality.&#xD;
&#xD;
      Indeed, it can lead to kidney failure, liver failure, prolonged ileus, scarring&#xD;
      complications, and neurological disorders. Clinical and ultrasound indications have been&#xD;
      described to diagnose this condition.&#xD;
&#xD;
      To date, this phenomenon is poorly known and not described in intensive care patients outside&#xD;
      the cardiac context. However, intensive care patients can present the risk factors associated&#xD;
      with the occurrence of congestion: acute cardiac failure, significant water-salt overload,&#xD;
      and/or fluid distribution anomalies. Thus, observational studies have found an association&#xD;
      between the input-output balance, the quantity of salt-water intake, the presence of right&#xD;
      heart dysfunction and the occurrence of acute kidney failure, digestive disorders, hypoxemia&#xD;
      and a prolonged stay in intensive care. The presence of a congestive condition is medically&#xD;
      treatable since diuretic decongestion is associated with improved cardiac outcomes.&#xD;
&#xD;
      It is therefore necessary, in an intensive care context, to be able to define and diagnose&#xD;
      this state of venous congestion, to study its prevalence, and to confirm the existence of a&#xD;
      link with organ failure in order to pave the way to known adapted treatment options.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 6, 2020</start_date>
  <completion_date type="Anticipated">November 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the presence of venous congestion</measure>
    <time_frame>From date of inclusion until the date of discharge from hospital or date of death from any cause, whichever came first, assessed up to 28 day</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">305</enrollment>
  <condition>Venous Congestion</condition>
  <condition>Organ Dysfunction Syndrome</condition>
  <arm_group>
    <arm_group_label>patient</arm_group_label>
    <description>Patient admitted to intensive care for less than 24 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>collection of biological parameters</intervention_name>
    <description>haemoglobin, haematocrit, sodium, chloraemia, total protein, albumin, L-lactate, pro-BNP, creatinine, uremia, AST, ALT, GGT, ALP, bilirubin, prothrombin time, urinary test if available.</description>
    <arm_group_label>patient</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>collection of echographic parameters</intervention_name>
    <description>echocardiography (FEVG, subaortic ITV before and after LJP, cardiac index, MAPSE, mitral flow doppler, RVFAC, FEVD, STDVD, VD/VG ratio, TAPSE, tricuspid S wave, IT with PAPs, tricuspid flow doppler), Doppler of suprahepatic veins (S wave, D wave, S/D ratio), renal doppler (VII, RRI, aspect of venous flow in cortical and hilar), femoral venous doppler, doppler of the portal trunk, diameter of the VCI.</description>
    <arm_group_label>patient</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>collection of clinical parameters</intervention_name>
    <description>eason for hospitalisation, co-morbidities, IGS2 score, SOFA, haemodynamic signs (BP, HR, CVP), sinus rhythm or not, temperature, diuresis, weight, input-output assessment, use of dialysis, ventilatory parameters (intubation, mode, FiO2(%), Vt, FR, PEEP, plateau pressure, driving pressure), state of shock (sepsis, postoperative, haemorrhagic, cardiogenic), transfusion (type, number), catecholamines (type, dose, duration), diuretics and dose, clinical criteria of venous congestion (jugular turgidity, hepato-jugular reflux, hepatosplenomegaly, pitting oedemas of the lower limbs, hepatalgia), neurological evaluation (Glasgow Coma Scale, CAM-ICU), time to resume enteral feeding and bowel movements, weight.</description>
    <arm_group_label>patient</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patient admitted to intensive care for less than 24 hours&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult&#xD;
&#xD;
          -  Patient who has expressed his or her non-opposition to the collection of data (or the&#xD;
             health care proxy, or a close relative if the patien is unable to receive the&#xD;
             information)&#xD;
&#xD;
          -  Patient admitted to intensive care for less than 24 hours.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Person not affiliated to the national health insurance&#xD;
&#xD;
          -  Minor, protected major&#xD;
&#xD;
          -  Pregnant or breastfeeding women&#xD;
&#xD;
          -  Anechogenicity confirmed by the operator&#xD;
&#xD;
          -  Chronic atrial fibrillation&#xD;
&#xD;
          -  Mechanical cardiac assistance&#xD;
&#xD;
          -  Uncontrolled blood pressure (MAP &lt; 65 mmHg)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pierre-grégoire GUINOT</last_name>
    <phone>03 80 28 13 09</phone>
    <phone_ext>+33</phone_ext>
    <email>pierregregoire.guinot@chu-dijon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chu Dijon Bourogne</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre-grégoire GUINOT</last_name>
      <phone>03 80 28 13 09</phone>
      <phone_ext>+33</phone_ext>
      <email>pierregregoire.guinot@chu-dijon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 23, 2020</study_first_submitted>
  <study_first_submitted_qc>December 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 23, 2020</study_first_posted>
  <last_update_submitted>December 17, 2020</last_update_submitted>
  <last_update_submitted_qc>December 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

